On the recordMarch 22, 2023
By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.
Source
congress.govEditor's note · Context
Discusses a bill aimed at improving generic drug approval and reducing prices.
Share & report
More from Maggie Hassan
Sep 24, 2024
Once the Department of Defense fully implements this law it will provide additional safeguards against conflicts of interest that compromise our national security.
Sep 23, 2024
It is outrageous that these companies...are putting profiting off of their deals with the Saudis over protecting the national security interests of the United States.
Sep 18, 2024
I ask unanimous consent that the resolution be agreed to, the preamble be agreed to, and that the motions to reconsider be considered made and laid upon the table with no intervening action or debate. The PRESIDING OFFICER. Is there…
Sep 23, 2024
I continue to call on the FAR Council... to provide better guidance to agencies on how to handle conflicts of interest.
Other voices in this conversation
